Open AccessAcute liver failure after initiation of rivaroxaban: A case report and review of the literature
Author(s) -
Muhammad Baig,
Kenneth J. Wool,
Jewell H. Halanych,
Rehan A Sarmad
Publication year - 2015
Publication title -
north american journal of medical sciences
Language(s) - English
Resource type - Journals
eISSN - 2250-1541
pISSN - 1947-2714
DOI - 10.4103/1947-2714.166221
Subject(s) - rivaroxaban , medicine , furosemide , heart failure , discontinuation , atrial fibrillation , hepatic encephalopathy , liver function tests , liver failure , abdominal pain , gastroenterology , cirrhosis , warfarin
Rivaroxaban is a direct factor Xa inhibitor approved for the prevention of thromboembolism. Drug induced liver injury has been increasingly reported with rivaroxaban recently, but actual liver failure has not been reported.